A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Florian Krammer^{1

2}

Affiliations

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.
² Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.

PMID: 34239135
DOI: 10.1038/s41591-021-01432-4

Comment

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Florian Krammer. Nat Med. 2021 Jul.

. 2021 Jul;27(7):1147-1148.

doi: 10.1038/s41591-021-01432-4.

Author

Florian Krammer^{1

2}

Affiliations

¹ Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.
² Department of Pathology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. florian.krammer@mssm.edu.

PMID: 34239135
DOI: 10.1038/s41591-021-01432-4

No abstract available

PubMed Disclaimer

Comment on

Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection.
Khoury DS, Cromer D, Reynaldi A, Schlub TE, Wheatley AK, Juno JA, Subbarao K, Kent SJ, Triccas JA, Davenport MP. Khoury DS, et al. Nat Med. 2021 Jul;27(7):1205-1211. doi: 10.1038/s41591-021-01377-8. Epub 2021 May 17. Nat Med. 2021. PMID: 34002089

Cited by

Humoral immune response characterization of heterologous prime-boost vaccination with CoronaVac and BNT162b2.
Rammauro F, Carrión F, Olivero-Deibe N, Fló M, Ferreira A, Pritsch O, Bianchi S. Rammauro F, et al. Vaccine. 2022 Aug 19;40(35):5189-5196. doi: 10.1016/j.vaccine.2022.07.023. Epub 2022 Jul 27. Vaccine. 2022. PMID: 35907676 Free PMC article.
Potent human broadly SARS-CoV-2-neutralizing IgA and IgG antibodies effective against Omicron BA.1 and BA.2.
Planchais C, Fernández I, Bruel T, de Melo GD, Prot M, Beretta M, Guardado-Calvo P, Dufloo J, Molinos-Albert LM, Backovic M, Chiaravalli J, Giraud E, Vesin B, Conquet L, Grzelak L, Planas D, Staropoli I, Guivel-Benhassine F, Hieu T, Boullé M, Cervantes-Gonzalez M, Ungeheuer MN, Charneau P, van der Werf S, Agou F; French COVID Cohort Study Group; CORSER Study Group; Dimitrov JD, Simon-Lorière E, Bourhy H, Montagutelli X, Rey FA, Schwartz O, Mouquet H. Planchais C, et al. J Exp Med. 2022 Jul 4;219(7):e20220638. doi: 10.1084/jem.20220638. Epub 2022 Jun 15. J Exp Med. 2022. PMID: 35704748 Free PMC article.
A Single Dose of a Hybrid hAdV5-Based Anti-COVID-19 Vaccine Induces a Long-Lasting Immune Response and Broad Coverage against VOC.
López MV, Vinzón SE, Cafferata EGA, Núñez FJ, Soto A, Sanchez-Lamas M, Afonso MJ, Aguilar-Cortes D, Ríos GD, Maricato JT, Braconi CT, Silveira VB, Andrad TM, Bonetti TCS, Ramos Janini LM, Girão MJBC, Llera AS, Gomez KA, Ortega HH, Berguer PM, Podhajcer OL. López MV, et al. Vaccines (Basel). 2021 Sep 29;9(10):1106. doi: 10.3390/vaccines9101106. Vaccines (Basel). 2021. PMID: 34696219 Free PMC article.
Mucosal immunization with lipopeptides derived from conserved regions of SARS-CoV-2 antigens induce robust cellular and cross-variant humoral immune responses in mice.
Patel RS, Agrawal B. Patel RS, et al. Front Immunol. 2023 Jun 2;14:1178523. doi: 10.3389/fimmu.2023.1178523. eCollection 2023. Front Immunol. 2023. PMID: 37334376 Free PMC article.
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trial.
Benkeser D, Montefiori DC, McDermott AB, Fong Y, Janes HE, Deng W, Zhou H, Houchens CR, Martins K, Jayashankar L, Castellino F, Flach B, Lin BC, O'Connell S, McDanal C, Eaton A, Sarzotti-Kelsoe M, Lu Y, Yu C, Borate B, van der Laan LWP, Hejazi NS, Kenny A, Carone M, Williamson BD, Garver J, Altonen E, Rudge T, Huynh C, Miller J, El Sahly HM, Baden LR, Frey S, Malkin E, Spector SA, Andrasik MP, Kublin JG, Corey L, Neuzil KM, Carpp LN, Pajon R, Follmann D, Donis RO, Koup RA, Gilbert PB; Immune Assays; Moderna Inc.; Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE); United States Government (USG)/CoVPN Biostatistics Teams. Benkeser D, et al. Sci Transl Med. 2023 Apr 19;15(692):eade9078. doi: 10.1126/scitranslmed.ade9078. Epub 2023 Apr 19. Sci Transl Med. 2023. PMID: 37075127 Free PMC article. Clinical Trial.

See all "Cited by" articles

References

1. Plotkin, S. A. & Gilbert, P. B. Clin. Infect. Dis. 54, 1615–1617 (2012). - DOI
1. Plotkin, S. A. Clin. Vaccine Immunol. 17, 1055–1065 (2010). - DOI
1. Khoury, D.S. et al. Nat. Med. https://doi.org/10.1038/s41591-021-01377-8 (2021).
1. Earle, K.A., et al. Vaccine https://doi.org/10.1016/j.vaccine.2021.05.063 (2021).
1. Aleman, A., et al.. Preprint at medRxiv https://doi.org/10.1101/2021.05.15.21256814 (2021).

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Affiliations

A correlate of protection for SARS-CoV-2 vaccines is urgently needed

Author

Affiliations

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous